(19)
(11) EP 4 188 959 A1

(12)

(43) Date of publication:
07.06.2023 Bulletin 2023/23

(21) Application number: 21850106.2

(22) Date of filing: 27.07.2021
(51) International Patent Classification (IPC): 
C07K 16/28(2006.01)
C07K 14/71(2006.01)
C07K 16/30(2006.01)
A61P 35/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 35/00; C07K 16/3092; C07K 2317/34; C07K 2317/622; C07K 2317/73; A61K 2039/505; C07K 14/7051; C07K 2319/03; C07K 2319/33
(86) International application number:
PCT/US2021/071017
(87) International publication number:
WO 2022/027039 (03.02.2022 Gazette 2022/05)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 29.07.2020 US 202063058044 P
07.12.2020 US 202063122234 P
19.02.2021 US 202163151380 P
09.04.2021 US 202163173083 P
05.05.2021 US 202163184724 P

(71) Applicant: Minerva Biotechnologies Corporation
Waltham, MA 02451 (US)

(72) Inventors:
  • BAMDAD, Cynthia
    Waltham, Massachusetts 02451 (US)
  • SMAGGHE, Benoit
    Waltham, Massachusetts 02451 (US)

(74) Representative: Mewburn Ellis LLP 
Aurora Building Counterslip
Bristol BS1 6BX
Bristol BS1 6BX (GB)

   


(54) ANTI-VARIABLE MUC1* ANTIBODIES AND USES THEREOF